Phase II Study of Lapatinib in Combination With Trastuzumab...

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)

Tabchy, A.B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Year:
2016
Language:
english
Journal:
Breast Diseases: A Year Book Quarterly
DOI:
10.1016/j.breastdis.2016.04.014
File:
PDF, 62 KB
english, 2016
Conversion to is in progress
Conversion to is failed